Dr. Simsek began by emphasizing that their group had previously shown that CD8+ T cells expressing PD-1 but lacking TIM-3 or LAG-3 are associated with improved clinical outcomes to anti–PD-1 ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

Democracy depends not just on officeholders, but on the quiet vigilance of institutional and civic actors—the novel “fourth ...

Cistanche is a supplement that may boost immunity, lower fatigue, and improve memory. Side effects may include nausea, vomiting, abdominal pain, and dizziness.

Merck reports phase 3 KEYNOTE-B96 trial meets secondary endpoint of OS in all comers population of patients with platinum-resistant recurrent ovarian cancer: Rahway, New Jersey Sa ...

When immune cells strike, precision is everything. New research reveals how natural killer and T cells orchestrate the ...

ORR and 79% DCR observed in heavily pretreated TMB-H or MSI-H/dMMR tumors across six major solid tumor types, including colorectal, lung, breast, ...

New research found that gene therapy for children with a form of severe combined immunodeficiency was successful in 95% of ...

The University of Adelaide's Professor Sarah Robertson has secured funding to take a closer look at how immune dysfunction can contribute to early ...

Scientists have found a way to transform hard-to-treat tumors into targets for the immune system. Using two protein stimulators, they activated strong T-cell and B-cell responses and built immune ...

Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...

Immune checkpoints include numerous inhibitory pathways essential for preserving self-tolerance and controlling the strength and duration of immune responses to prevent damage to healthy cells.